Author : Bin Li
Publisher : Frontiers Media SA
ISBN 13 : 2832541836
Total Pages : 236 pages
Book Rating : 4.8/5 (325 download)
Book Synopsis Novel Molecular Targets and Treatments for Gastroesophageal Cancer, 2nd edition by : Bin Li
Download or read book Novel Molecular Targets and Treatments for Gastroesophageal Cancer, 2nd edition written by Bin Li and published by Frontiers Media SA. This book was released on 2024-01-10 with total page 236 pages. Available in PDF, EPUB and Kindle. Book excerpt: Gastroesophageal cancer is among the most common malignant diseases worldwide and is associated with high mortality rates, leading to a substantial burden on public health and healthcare systems around the world. Chemotherapeutic drugs have achieved great success in the treatment of esophageal cancer; however, they also bring cytotoxicity to other organs and often have serious side effects. With the development of molecular diagnostics and biomarker discovery, the application of precision medicine has emerged to improve clinical outcomes. New antineoplastic therapy development is a timely topic in light of the recent development of precision medicine. New biotherapies aim to inhibit or regulate different targets, which are thought to be functionally selective or overexpressed in some types of tumors. In particular, progress has been made to understand the molecular biology of gastrointestinal cancer, resulting in the discovery of various molecular targets, such as KRAS, PD-1, PD-L1, EGFR, HER2 and VEGF. Moreover, anticancer agents, such as pembrolizumab, olaparib, trastuzumab, bevacizumab, either as single agents or in combination with conventional chemotherapy, have become part of the standard of care for treatment of advanced gastroesophageal cancer. This Research Topic provides a platform for recent studies on novel molecular targets and treatments for gastroesophageal cancer. Both Original Research articles and Reviews are welcome. Subjects may include but are not limited to: 1) Oncogenes and tumor suppressors; 2) Drug sensitivity/resistance; 3) Tumor metastasis and tumor microenvironment; 4) Biomarker discovery and epigenetic regulation.